BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28611465)

  • 1. Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
    Smith E; Palethorpe HM; Hayden AL; Young JP; Underwood TJ; Drew PA
    Sci Rep; 2017 Jun; 7(1):3368. PubMed ID: 28611465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival.
    Zhu X; Luo X; Feng G; Huang H; He Y; Ma W; Zhang C; Zeng M; Liu H
    PLoS One; 2019; 14(2):e0207341. PubMed ID: 30716092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T
    PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.
    Smith E; Ruszkiewicz AR; Jamieson GG; Drew PA
    Br J Cancer; 2014 Feb; 110(3):775-82. PubMed ID: 24357797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.
    Peng D; Hu TL; Jiang A; Washington MK; Moskaluk CA; Schneider-Stock R; El-Rifai W
    PLoS One; 2011; 6(7):e22009. PubMed ID: 21818286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
    Bjaanæs MM; Fleischer T; Halvorsen AR; Daunay A; Busato F; Solberg S; Jørgensen L; Kure E; Edvardsen H; Børresen-Dale AL; Brustugun OT; Tost J; Kristensen V; Helland Å
    Mol Oncol; 2016 Feb; 10(2):330-43. PubMed ID: 26601720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
    Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
    Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
    Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
    Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.
    Goh XY; Rees JR; Paterson AL; Chin SF; Marioni JC; Save V; O'Donovan M; Eijk PP; Alderson D; Ylstra B; Caldas C; Fitzgerald RC
    Gut; 2011 Oct; 60(10):1317-26. PubMed ID: 21478220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.
    Underwood TJ; Hayden AL; Derouet M; Garcia E; Noble F; White MJ; Thirdborough S; Mead A; Clemons N; Mellone M; Uzoho C; Primrose JN; Blaydes JP; Thomas GJ
    J Pathol; 2015 Feb; 235(3):466-77. PubMed ID: 25345775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
    Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
    Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
    Naumov VA; Generozov EV; Zaharjevskaya NB; Matushkina DS; Larin AK; Chernyshov SV; Alekseev MV; Shelygin YA; Govorun VM
    Epigenetics; 2013 Sep; 8(9):921-34. PubMed ID: 23867710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive silencing of p14ARF in oesophageal adenocarcinoma.
    Huang Y; Peters CJ; Fitzgerald RC; Gjerset RA
    J Cell Mol Med; 2009 Feb; 13(2):398-409. PubMed ID: 18410530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
    Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
    Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
    Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
    Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.
    Sundar R; Ng A; Zouridis H; Padmanabhan N; Sheng T; Zhang S; Lee MH; Ooi WF; Qamra A; Inam I; Hewitt LC; So JB; Koh V; Nankivell MG; Langley RE; Allum WH; Cunningham D; Rozen SG; Yong WP; Grabsch HI; Tan P
    Eur J Cancer; 2019 Dec; 123():48-57. PubMed ID: 31655359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
    Kaz AM; Wong CJ; Luo Y; Virgin JB; Washington MK; Willis JE; Leidner RS; Chak A; Grady WM
    Epigenetics; 2011 Dec; 6(12):1403-12. PubMed ID: 22139570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide methylation analysis identifies novel prognostic methylation markers in colon adenocarcinoma.
    Xue W; Wu X; Wang F; Han P; Cui B
    Biomed Pharmacother; 2018 Dec; 108():288-296. PubMed ID: 30223100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.